Skip to main content
SpringerLink
Log in

Clinical Presentation and Natural History of Mesothelioma: Abdominal

  • Chapter
Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF Jr. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 1987;78(6):1053–1060.

    PubMed  CAS  Google Scholar 

  2. Roggli VL. Malignant mesothelioma and duration of asbestos exposure: correlation with tissue mineral fibre content. Ann Occup Hyg 1995;39(3):363–374.

    Article  PubMed  CAS  Google Scholar 

  3. Roggli VL, Oury TD, Moffatt EJ. Malignant mesothelioma in women. Anat Pathol 1997;2:147–163.

    PubMed  CAS  Google Scholar 

  4. Suzuki Y. Pathology of human malignant mesothelioma-preliminary analysis of 1517 mesothelioma cases. Ind Health 2001;39(2):183–185.

    PubMed  CAS  Google Scholar 

  5. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol 2002;26(2):55–65.

    Article  PubMed  Google Scholar 

  6. Britton M. The epidemiology of mesothelioma. Semin Oncol 2002;29(1):18–25.

    Article  PubMed  Google Scholar 

  7. Neumann V, Gunthe S, Mulle KM, Fischer M. Malignant mesothelioma-German mesothelioma register 1987–1999. Int Arch Occup Environ Health 2001;74(6):383–395.

    Article  PubMed  CAS  Google Scholar 

  8. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96(6 Pt 1):746–755.

    PubMed  CAS  Google Scholar 

  9. Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24(9):1183–1200.

    PubMed  CAS  Google Scholar 

  10. Clement PB. Diseases of the peritoneum. In: Kurman RJ, ed. Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, 1994:647–703.

    Google Scholar 

  11. Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25(10):1304–1309.

    Article  PubMed  CAS  Google Scholar 

  12. Daya D, McCaughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 1990;65(2):292–296.

    Article  PubMed  CAS  Google Scholar 

  13. Shanks JH, Harris M, Banerjee SS, et al. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 2000;24(2):285–294.

    Article  PubMed  CAS  Google Scholar 

  14. Bollinger DJ, Wick MR, Dehner LP, Mills SE, Swanson PE, Clarke RE. Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison. Am J Surg Pathol 1989;13(8):659–670.

    PubMed  CAS  Google Scholar 

  15. Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol 1997;21(4):392–398.

    Article  PubMed  CAS  Google Scholar 

  16. Kerrigan SA, Turnnir RT, Clement PB, Young RH, Churg A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer 2002;94(2):378–385.

    Article  PubMed  Google Scholar 

  17. Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 1988;6(1):147–153.

    PubMed  CAS  Google Scholar 

  18. Antman KH, Corson JM, Li FP, et al. Malignant mesothelioma following radiation exposure. J Clin Oncol 1983;1(11):695–700.

    PubMed  CAS  Google Scholar 

  19. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999;70(1):6–12.

    Article  PubMed  CAS  Google Scholar 

  20. Jones DE, Silver D. Peritoneal mesotheliomas. Surgery 1979;86(4):556–560.

    PubMed  CAS  Google Scholar 

  21. Piccigallo E, Jeffers LJ, Reddy KR, Caldironi MW, Parenti A, Schiff ER. Malignant peritoneal mesothelioma. A clinical and laparoscopic study of ten cases. Dig Dis Sci, 1988;33(5):633–639.

    Article  PubMed  CAS  Google Scholar 

  22. van Gelder T, Hoogsteden HC, Versnel MA, de Beer PH, Vandenbroucke JP, Planteydt HT. Malignant peritoneal mesothelioma: a series of 19 cases. Digestion 1989;43(4):222–227.

    Article  PubMed  Google Scholar 

  23. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31(1):15–24.

    PubMed  CAS  Google Scholar 

  24. Krismann M, Muller KM, Jaworska M, Johnen G. Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J Pathol 2002;197(3):363–371.

    Article  PubMed  CAS  Google Scholar 

  25. Chang K, Pai LH, Pass H, et al. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 1992;16(3):259–268.

    Article  PubMed  CAS  Google Scholar 

  26. Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Nat Acad Sci USA 1996;93(1):136–140.

    Article  PubMed  CAS  Google Scholar 

  27. Kojima T, Oh-eda M, Hattori K, et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem 1995;270(37):21984–21990.

    Article  PubMed  CAS  Google Scholar 

  28. Scholler N, Fu N, Yang Y, et al. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Nat Acad Sci USA 1999;96(20):11531–11536.

    Article  PubMed  CAS  Google Scholar 

  29. Hassan R, Kreitman R, Strauss L, et al. SS1(dsFv)PE38 anti-mesothelin immunotoxin in advanced malignancies: phase I and pharmacokinetic study of alternate-day infusion. Proc Am Soc Clin Oncol 2002;21(A29).

    Google Scholar 

  30. Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, et al. Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin Oncol 2002;29(1):51–61.

    Article  PubMed  Google Scholar 

  31. Taub RN, Keohan ML, Chabot JC, Fountain KS, Plitsas M. Peritoneal mesothelioma. Curr Treat Options Oncol 2000;1(4):303–312.

    PubMed  CAS  Google Scholar 

  32. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983;77(4):321–343.

    Article  PubMed  CAS  Google Scholar 

  33. Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH, Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 2000;87(11):1587–1593.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research and Treatment Center, University of New Mexico School of Medicine, Albuquerque, NM, USA

    Claire F. Verschraegen MD

  2. Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA

    Charles R. Key MD, PhD

  3. Laboratory of Molecular Biology, National Cancer Institute/National Institutes of Health, Bethesda, MD, USA

    Raffit Hassan MD

Authors
  1. Claire F. Verschraegen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles R. Key MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raffit Hassan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Verschraegen, C.F., Key, C.R., Hassan, R. (2005). Clinical Presentation and Natural History of Mesothelioma: Abdominal. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_25

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation